Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Maravai Lifesciences Holdings (MRVI) Goodwill & Intangibles: 2020-2024

Historic Goodwill & Intangibles for Maravai Lifesciences Holdings (MRVI) over the last 5 years, with Dec 2024 value amounting to $354.8 million.

  • Maravai Lifesciences Holdings' Goodwill & Intangibles fell 15.61% to $315.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was $315.3 million, marking a year-over-year decrease of 15.61%. This contributed to the annual value of $354.8 million for FY2024, which is 35.13% down from last year.
  • According to the latest figures from FY2024, Maravai Lifesciences Holdings' Goodwill & Intangibles is $354.8 million, which was down 35.13% from $547.0 million recorded in FY2023.
  • Over the past 5 years, Maravai Lifesciences Holdings' Goodwill & Intangibles peaked at $547.0 million during FY2023, and registered a low of $270.4 million during FY2021.
  • Moreover, its 3-year median value for Goodwill & Intangibles was $500.4 million (2022), whereas its average is $467.4 million.
  • In the last 5 years, Maravai Lifesciences Holdings' Goodwill & Intangibles skyrocketed by 85.07% in 2022 and then slumped by 35.13% in 2024.
  • Over the past 5 years, Maravai Lifesciences Holdings' Goodwill & Intangibles (Yearly) stood at $402.0 million in 2020, then slumped by 32.74% to $270.4 million in 2021, then soared by 85.07% to $500.4 million in 2022, then increased by 9.32% to $547.0 million in 2023, then plummeted by 35.13% to $354.8 million in 2024.